Autologous PRP Intra Ovarian Infusion to Restore Ovarian Function in Menopausal Women
Recruiting now · Phase 2/Phase 3
Conditions studied: Infertility, Female, Anovulatory Infertility, Menopause, Amenorrhea
In brief
Autologous PRP intra ovarian infusion may restore ovarian function, may promote folliculogenesis and may improve hormonal profile of women in menopause.
Key facts
- Study ID
- NCT03916978
- Run by
- Genesis Athens Clinic
- People needed
- 100
- Starts
- 2019-05-21
- Expected to finish
- 2028-07-30
- Last updated by the study team
- 2026-07-08
Who can join
Age: 45 and older, up to 55. Sex: female. Healthy volunteers: accepted.
You may qualify if…
- Age between 45-55 years old
- Amenorrhea for at least 12 months
- Discontinuation of any complementary/adjuvant treatment including hormone replacement, acupuncture, and botanotherapy, for at least three months prior to recruitment.
- Willing to comply with study requirements
You may not qualify if…
- Any pathological disorder related to reproductive system anatomy
- Previous POI diagnosis
- Abnormal karyotype
- Endometriosis
- Adenomyosis
- Fibroids and adhesions
- Infections in reproductive system
- Current or previous diagnosis of reproductive system cancer
- History of familiar cancer in reproductive system
- Severe male factor infertility
- Prior referral for PGT
- Ovarian inaccessibility
- Endocrinological disorders (Hypothalamus-Pituitary disorders, thyroid dysfunction, diabetes mellitus, metabolic syndrome)
- BMI>30 kg/m2 or BMI<18.5 kg/m2
- Systematic autoimmune disorders
Where it is running
- Genesis AC — Athens, Greece (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.